tiprankstipranks
Trending News
More News >
Fennec Pharmaceuticals (TSE:FRX)
:FRX
Canadian Market

Fennec Pharmaceuticals (FRX) Income Statement

Compare
27 Followers

Fennec Pharmaceuticals Income Statement

Last quarter (Q3 2025), Fennec Pharmaceuticals's total revenue was $12.46M, an increase of 78.69% from the same quarter last year. In Q3, Fennec Pharmaceuticals's net income was $-638.00K. See Fennec Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 47.54M$ 21.25M$ 1.53M$ 0.00$ 170.00K
Gross Profit
$ 44.35M$ 19.99M$ 1.45M$ 0.00$ 170.00K
Operating Expenses
$ 41.79M$ 32.76M$ 24.04M$ 17.22M$ 18.05M
Depreciation and Amortization
$ 800.00K$ 287.00K$ 149.00K$ 17.22M$ 402.00K
EBITDA
$ 4.80M$ -12.65M$ -22.74M$ -17.18M$ -17.98M
Operating Income
$ 2.57M$ -12.77M$ -22.59M$ -17.22M$ -17.89M
Other Income/Expenses
$ -2.64M$ -3.27M$ -1.13M$ -123.00K$ -224.00K
Pretax Income
$ -71.00K$ -16.05M$ -23.71M$ -17.35M$ -18.11M
Net Income
$ -436.00K$ -16.05M$ -23.86M$ -17.46M$ -18.11M
Per Share Metrics
Basic EPS
$ -0.02$ -0.60$ -0.91$ -0.67$ -0.76
Diluted EPS
$ -0.02$ -0.60$ -0.91$ -0.67$ -0.76
Weighted Average Shares Outstanding
21.80M 26.57M 26.27M 25.89M 23.70M
Weighted Average Shares Outstanding (Diluted)
27.30M 26.57M 26.27M 26.01M 23.70M
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History